Abstract: Some embodiments disclosed herein relate to devices and methods for controlling placement of intraocular implants within a patient's eye including but not limited to placement within or near the collector ducts of Schlemm's canal located behind the trabecular meshwork. In some embodiments, a handheld peristaltic rotor device having a compression element can be positioned on a corneal surface of the eye and rotated to create a peristaltic movement of blood in one or more episcleral veins to generate blood reflux within Schlemm's canal such that one or more collector ducts, or channels, of Schlemm's canal can be located. In some embodiments, an implant can be implanted near the identified location of the one or more collector ducts, or channels.

Abstract: This disclosure includes a guidance system for coupling vehicles. The system has a hub and a first length of material secured to the hub and configured for spacing the hub from a coupling device of a first vehicle. A second length of material is secured to the hub and configured for spacing the hub from a wheel of a second vehicle for coupling with the first vehicle.

Abstract: Polycarbamide coating compositions and secondary diamine curing agents used to produce the coating compositions are disclosed. Curing agent compositions comprising: (a) the reaction product of bis(4-aminocyclohexyl) methane and ethyl ester of 2-butendioc acid; and (b) the reaction product of bis(4-amino-3-methylcyclohexyl)methane and ethyl ester of 2-butendioic acid; and (c) at least one polyol are also disclosed. One aspect of the disclosure relates to a non-aqueous coating composition comprising the disclosed amine curing agents with a polyisocyanate resin. The coating compositions are suitable for use as direct to metal coatings or top coats. Methods of producing the curing agents and the coating compositions are also disclosed.

Abstract: Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space.

Abstract: A cannabinoid material as active agent containing formulation comprising the active agent, an HFA propellant, and optionally a co-solvent is disclosed. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 50° C.

Abstract: A cannabinoid active agent containing formulation comprising the active agent, an HFA propellant, optionally a terpenoid, and optionally a co-solvent is disclosed. At least two cannabinoids, each of which is required to be present in amounts of at least 20% of the total cannabinoid content of formulation are required to be present. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 40° C.

Abstract: According to one embodiment, a vehicle powertrain includes an engine having a first locking feature defining first mating surfaces, and a differential coupled to a transfer case via a driveshaft. The differential includes a second locking feature defining second mating surfaces. The first and second locking features are engaged such that the first and second mating surfaces are disposed against each other connecting the engine and the differential. A fastener is disposed within the engine and the differential.

Abstract: Gonioscope devices are disclosed herein that are configured to enable a medical professional to view structure inside the eye that is ordinarily hidden from normal view. The gonioscope can be an integrally molded single piece that includes both a handle and a gonioscopic optical element. The proximal surface can have a viewing area and a light diffusing area. A recess can provide access to a wound site on the eye while the gonioscope is used for viewing. The handle can be configured to encourage proper alignment of the gonioscope with the eye. The gonioscope can provide an optical fixation point for the subject to focus on to facilitate proper alignment of the eye. The gonioscope can have one or more retention elements configured to engage the tissue of the eye around the contact surface to stabilize the gonioscope. The gonioscope can couple to a lid speculum.

Abstract: A cannabinoid material as active agent containing formulation comprising the active agent, an HFA propellant, and optionally a co-solvent is disclosed. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 50° C.

Abstract: An electronic device includes a substrate having a top surface, a bottom surface and at least one opening therethrough. The substrate has a circuit. A switch mechanism is mounted to the substrate and is electrically connected to the circuit. The switch mechanism has an actuator configured to activate the switch mechanism. The switch mechanism has a housing holding the actuator and leads extending from the housing. The leads are electrically connected to the circuit. The switch mechanism is mounted to the substrate in the opening such that at least a portion of the housing is positioned below the top surface.

Abstract: A solar junction box for a solar panel having a semiconductor layer including at least one photovoltaic cell and a foil electrically connected to the at least one cell, the solar panel having a glass layer above the semiconductor layer and a back sheet below the semiconductor layer includes a housing having walls defining a cavity. The housing is mounted at an edge of the solar panel. A terminal is received in the cavity and is configured to be terminated to the foil. An edge flap extends from the housing. The edge flap has an edge seal configured to be applied to the edge of the solar panel to seal the foil at the edge of the solar panel.

Abstract: A gonioscopic attachment can attach to a gonioscope and can include atraumatic retention elements that are configured to engage an eye to retain the gonioscope relative to the eye. The gonioscopic attachment can be configured to position the gonioscope so that at least a portion of the concave distal surface of the gonioscopic optical element is spaced apart from the eye, and/or so that the curvature of the distal surface is angularly offset from the curvature of the eye. The gonioscope can include a fixation point configured to be visible to the subject when the gonioscope is positioned on the eye. In some embodiments, the retention elements can be incorporated directly into the gonioscope. A coupling mechanism can couple the gonioscope to a lid speculum. The gonioscope can include a light pipe, which can be configured to directly light into the eye.

Abstract: A cannabinoid material as active agent containing formulation comprising the active agent, an HFA propellant, and optionally a co-solvent is disclosed. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 50° C.

Abstract: In one aspect, a computing apparatus is configured to: capture first images of customers who have watched a digital sign, using a digital camera attached to the digital sign positioned in vicinity of a retail location; identify characteristics of the customers based on the first images; identify, using the characteristics, a subset of customers who have made payment transactions at the retail location through a transaction handler; determine an aggregated spending profile based on transactions of the subset of customers recorded by the transaction handler; and arrange content on the digital sign based on the aggregated spending profile. The computing apparatus may be further configured to capture second images of the customers who have made payment transactions at the retail location through the transaction handler, using a digital camera attached to a point of sale (POS) station at the retail location, and to correlate the first and second images to identify the subset.

Abstract: A solar junction box for a solar panel having at least one photovoltaic cell and a foil electrically connected to the at least one cell includes a housing having a base and walls defining a cavity. The housing is configured to be mounted to the solar panel. The base has at least one foil opening. A protection device is received in the cavity. A terminal is received in the cavity. The terminal has a protection device contact terminated to the protection device and a foil contact being crimped to the foil to electrically connect the terminal to the foil.

Abstract: This disclosure includes a guidance system for coupling vehicles. The system has a hub and a first length of material secured to the hub and configured for spacing the hub from a coupling device of a first vehicle. A second length of material is secured to the hub and configured for spacing the hub from a wheel of a second vehicle for coupling with the first vehicle.

Abstract: In one aspect, a computing apparatus is configured to: capture first images of customers who have watched a digital sign, using a digital camera attached to the digital sign positioned in vicinity of a retail location; identify characteristics of the customers based on the first images; identify, using the characteristics, a subset of customers who have made payment transactions at the retail location through a transaction handler; determine an aggregated spending profile based on transactions of the subset of customers recorded by the transaction handler; and arrange content on the digital sign based on the aggregated spending profile. The computing apparatus may be further configured to capture second images of the customers who have made payment transactions at the retail location through the transaction handler, using a digital camera attached to a point of sale (POS) station at the retail location, and to correlate the first and second images to identify the subset.

Abstract: The present invention relates to amino silicone nanoemulsions. More specifically, the present invention relates to amino silicone nanoemulsions that may be used to protect surfaces from being soiled or wetted.

Abstract: A cannabinoid material as active agent containing formulation comprising the active agent, an HFA propellant, and optionally a co-solvent is disclosed. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 50° C.